Clinical Roundup

Clinical Roundup

IU study: Vaccine protects most cancer patients from COVID-19, but risk remains higher for patients with blood cancers

Using the nation’s largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected most cancer patients from getting COVID-19. However, patients with certain types of cancer have a higher and widely varied risk of breakthrough infections after receiving the vaccine.
Clinical Roundup

Real-world data show potential of Cosela to reduce myelosuppression in ES-SCLC treated with chemo

A retrospective, observational study sponsored by G1 Therapeutics described the burden of myelosuppression and its impact on healthcare resource utilization in 3,277 patients being treated with chemotherapy for extensive-stage small-cell lung cancer. The study also described patient outcomes from 21 patients receiving Cosela (trilaciclib) prior to chemotherapy.